Brookstone Capital Management Purchases 2,996 Shares of Synopsys, Inc. $SNPS

Brookstone Capital Management boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 16.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,033 shares of the semiconductor company’s stock after acquiring an additional 2,996 shares during the period. Brookstone Capital Management’s holdings in Synopsys were worth $8,339,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Sankala Group LLC purchased a new position in shares of Synopsys during the 4th quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Synopsys during the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd purchased a new position in Synopsys during the fourth quarter worth about $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys during the fourth quarter worth about $32,000. Finally, Osbon Capital Management LLC bought a new position in Synopsys in the 4th quarter worth about $34,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Up 2.0%

Shares of NASDAQ:SNPS opened at $464.58 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73. The company has a market cap of $88.96 billion, a PE ratio of 107.54, a P/E/G ratio of 2.68 and a beta of 1.22. The stock’s 50-day moving average is $480.33 and its 200 day moving average is $462.32.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the prior year, the company earned $3.67 earnings per share. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Piper Sandler raised their target price on shares of Synopsys from $430.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, May 28th. Stifel Nicolaus lifted their target price on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Needham & Company LLC reissued a “buy” rating and issued a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research report on Wednesday, May 27th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $563.81.

Insider Buying and Selling at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.